October 26, 2020 – MLM Medical Labs (“MLM”), a Great Point Partners portfolio company, today announced the acquisition of MD Biosciences, Inc., based in Oakdale, MN, USA. MD Biosciences is a global
What might just look like a cardboard box with a styrofoam inlet and a gel pack is MLM’s patented solution for ambient transport samples. Already two years ago it was patented in Italy in Germany
United States Patent and Trademark Office grants patent for the MLM Safeguard Box Read More »
The BNTM II system from Siemens Healthineers is a nephelometric analyzer that complements MLM’s excellent lab device portfolio, in the field of protein analysis. With more than 65 assay protocols
Siemens BN II System expands MLM’s lab portfolio Read More »
August 19, 2020, Dusseldorf, Germany – MLM Medical Labs GmbH (“MLM”), a Great Point Partners (“GPP”) portfolio company, today announced that Isabel Struik has joined the team as VP Sales & Marketing.
MLM Medical Labs appoints Isabel Struik as VP Sales & Marketing Read More »
Our Navigators will be online this weekend for The International Society on Thrombosis and Haemostasis (ISTH) virtual meeting. View our poster, Tetraspanin CD9 Regulates GPIIb-IIIa-Mediated Platelet
ISTH 2020 – Virtual Meeting Read More »
We are excited to announce that CirQuest Labs is now a member of the California based life science association, Biocom. Biocom works on behalf of more than 1,300 member companies to drive public policy
MLM Memphis, former CirQuest, joins BIOCOM Read More »
July 8, 2020, Dusseldorf, Germany – MLM Medical Labs GmbH (“MLM”), a Great Point Partners (“GPP”) portfolio company, today announced the acquisition of CirQuest Labs, based in Memphis, TN, USA.
MLM Medical Labs expands to the US and nominates Thomas Wollman as member of the board Read More »
One of the most frequented services in our central lab is the performance of multiplex assays. Seven years ago, we decided for MSDs high-performance electrochemiluminescence
Doubled capacity for single and multiplex assays Read More »
The current SARS-CoV-2 pandemic is the predominant topic in all aspects of our lives.
In order to support companies and institutions in the re-establishment of their business activities and
Extended diagnostic and MLM Kit Building services during SARS-CoV-2 pandemic Read More »
MLM has expanded its ability to support both oncology and immunology clinical trials through the acquisition of the Beckman CytoFLEX V2-B5-R3 Cytometer.
